RxDoctor Payments Data

Douglas Logan

Internal Medicine · Cincinnati, OHNPI 1659585289

Payments from drug & device makers

What this record shows

Novartis accounts for 73.4% of it on its own, with 3 other manufacturers making up the rest.

$1,244in general payments, 2019–2025

Across 10 payments — averaging $124.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$913
  • Modernatx, Inc.$300
  • Corium, LLC$17
  • Noven Therapeutics, LLC$14
$4,681,585in research payments, 2019–2025

Across 1,066 payments — averaging $4391.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$2.8M
  • Pfizer$814K
  • Novavax Inc$444K
  • Novartis$263K
  • Sanofi US Services Inc.$102K
  • Journey Medical Corporation$94K
  • plus $136K from 4 others

What the payments were for

  • Travel & lodging$72959%
  • Food & beverage$51541%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis3$913
Modernatx, Inc.5$300
Corium, LLC1$17
Noven Therapeutics, LLC1$14

How this compares

$1,244 in reported general payments places this provider in the 75th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine Sulfate18$2,104
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine31$1,314
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine18$1,142
Methylphenidate Hcl13$335

Paid to pharmacies, not to this prescriber.

Other internal medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →